细胞竞争通过多阶段的过程促进了转移性肠癌
Ana Krotenberg Garcia1, Mario Ledesma-Terrón1,2, Maria Lamprou1
1Division of Developmental Biology, Institute of Biodynamics and Biocomplexity, Department of Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, the Netherlands.
iScience
|May 6, 2024
概括
癌细胞利用细胞竞争进行肝脏转移. 这一过程涉及肝脏原生细胞紧缩,细胞循环停止和分化,使它们易受癌细胞竞争的影响.
科学领域:
- 在瘤学瘤学.
- 发展生物学 发展生物学
- 细胞生物学 细胞生物学
背景情况:
- 细胞竞争对于组织平衡和质量控制至关重要.
- 癌细胞可以为自己的利益劫持细胞竞争,特别是在转移.
研究的目的:
- 通过使用混合的小鼠器官和微组织,研究细胞竞争对肝转移的影响.
- 阐明肝脏转移性竞争的多阶段过程.
主要方法:
- 产生混合的小鼠器官和微组织.
- 观察肝细胞和肠癌细胞之间的相互作用.
主要成果:
- 肝脏中的转移性竞争最初不会诱导肝脏前代细胞的亡.
- 肝脏的祖先经历了紧缩,细胞循环停止和强制分化.
- 新分化的肝细胞表现出减少的健康状况,使肠癌细胞能够超越竞争对手.
- 癌细胞利用肝脏中的多样化的上皮细胞群作为生长的支架.
结论:
- 组织特异性的细胞竞争机制是转移性肠癌的基本驱动因素.
- 癌细胞通过多个阶段的过程利用肝脏前代细胞,包括分化和减少细胞适应性.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


